Prostate cancer risk andIRS1, IRS2, IGF1, andINS polymorphisms: Strong association ofIRS1 G972R variant and cancer risk
- 27 January 2005
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 64 (2) , 168-174
Abstract
BACKGROUND As cellular proliferation is central to the carcinogenic process, pathways that regulate proliferation may be important. Therefore, genes in the insulin and the insulin‐like growth factor signaling pathways are plausible candidates for susceptibility genes for prostate cancer. We hypothesized that functional polymorphisms in INS, IRS1, IRS2, and IGF1 may be associated with prostate cancer. METHODS We studied 199 incident prostate cancer cases and 267 age‐matched controls. Genotyping was performed for the INS +1127 Ins‐PstI, IRS1 G972R, IRS2 G1079D, and the IGF1 CA‐repeat polymorphisms. Outcomes were prostate cancer, Gleason score, and AJCC stage. RESULTS The IRS1 G972R GR/RR genotypes were associated with a significant 2.8‐fold increased risk for prostate cancer (95% CI 1.5–5.1, P = 0.0007). The other variants were not significantly associated with prostate cancer. The IRS1 G972R GR/RR genotypes were also significantly associated with more advanced Gleason score (P = 0.001) and AJCC stage (P = 0.004). CONCLUSIONS These results support a role of the insulin and/or insulin‐like growth factor pathways in the etiology of prostate cancer.Keywords
This publication has 32 references indexed in Scilit:
- Screen‐detected prostate cancer and the insulin‐like growth factor axis: Results of a population‐based case‐control studyInternational Journal of Cancer, 2004
- Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up‐regulates IGF binding protein‐3, and suppresses MMP‐2 expressionThe Journal of Pathology, 2003
- The IGF‐1 receptor in cancer biologyInternational Journal of Cancer, 2003
- Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cellsOncogene, 2001
- The contradictions of the insulin-like growth factor 1 receptorOncogene, 2000
- IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutationOncogene, 2000
- The IGF-I Receptor in Cancer ResearchExperimental Cell Research, 1999
- Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I ReceptorsJournal of Biological Chemistry, 1996
- Association of insulin receptor substrate-1 with integrinsScience, 1994
- Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitusThe Lancet, 1993